Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Douglas Elder"'
Publikováno v:
International Journal of Cardiology. 288:94-99
Background Atrial fibrillation (AF) is a major preventable risk factor for stroke and may be silent in elderly individuals who are at especially high risk. This paper describes the first phase of implementation of a clinical AF detection programme in
Autor:
Adelle Dawson, Pradeep Mohan, Aaron Tee, Chim C. Lang, Jacob George, Fiona Shearer, Anna Maria Choy, Alex S. F. Doney, Douglas Elder, Peter Currie, Ify R. Mordi, Helen M. Parry
Publikováno v:
Scottish Medical Journal. 64:NP46-NP53
Autor:
Jagdeep Singh, Douglas Elder, Allan D. Struthers, Louise A. Donnelly, Anna-Maria J. Choy, Chim C. Lang, Jacob George, Alex S. F. Doney, Daniel Levin
Publikováno v:
European Journal of Heart Failure. 18:94-102
Aims Controversy exists regarding the importance of glycaemic control in patients with type 2 diabetes mellitus (T2DM) and chronic heart failure (CHF) based on conflicting reports using single baseline glycosyated haemoglobin (HbA1c). Using the time-
Publikováno v:
Lung. 193:487-495
Left ventricular hypertrophy (LVH) is a significant cardiac risk factor, associated with increased mortality. The impact of LVH on mortality in chronic obstructive pulmonary disease (COPD) is unknown. We evaluated the impact of LVH on mortality in CO
Autor:
Jacob George, Douglas Elder, Benjamin R. Szwejkowski, Harshal Deshmukh, Chim C. Lang, Andrew R Goudie
Publikováno v:
European Journal of Heart Failure. 17:90-97
Background The use of oral anticoagulation in patients with heart failure in sinus rhythm remains controversial as previous large randomized controlled trials (RCTs) have not shown a survival benefit. However, heterogeneity exists among heart failure
Autor:
Douglas Elder, Azeem Majeed, Awsan Noman, Allan D. Struthers, Jeremy C Wyatt, Anna Maria Choy, Simon Ogston, Thomas M. MacDonald, Maheshwar Pauriah, Chim C. Lang
Publikováno v:
Heart. 100:867-872
To determine all-cause mortality in patients with a first myocardial infarct who were treated with simvastatin compared with high-potency statin and simvastatin/ezetimibe combination.Despite statin use, residual cardiovascular risk remains. Therapeut
Publikováno v:
Expert Review of Cardiovascular Therapy. 11:107-114
Aortic valve disease (AVD) is the most common form of valvular heart disease in the western world. The only proven therapy for severe AVD is open aortic valve replacement, with trans-catheter aortic valve implantation emerging as a promising modality
Publikováno v:
Cardiovascular therapeutics. 35(3)
Introduction: \ud \ud Amiodarone is associated with significant long-lasting adverse drug reactions (ADRs). Guidelines recommend laboratory monitoring during long-term use. However, data of compliance with laboratory monitoring are lacking.\ud Aims:
Autor:
Allan D. Struthers, Maheshwar Pauriah, Douglas Elder, Nuala A. Booth, Chim C. Lang, Tiong K. Lim, Faisel Khan, Gwen Kennedy, Valerie Godfrey, Jill J. F. Belch
Publikováno v:
Clinical Science (London, England : 1979)
BNP (B-type natriuretic peptide) has been reported to be elevated in preclinical states of vascular damage. To elucidate the relationship between plasma BNP and endothelial function, we have investigated the relationship between BNP and endothelial f
Autor:
Benjamin R. Szwejkowski, Adnan Nadir, Stuart D. Pringle, Chim C. Lang, Jacob George, Maheshwar Pauriah, Alex S. F. Doney, Li Wei, Anna Maria Choy, Tiong K. Lim, Sushma Rekhraj, Allan D. Struthers, Douglas Elder, Renata Libianto
Publikováno v:
Journal of the American College of Cardiology. 58:2084-2091
Objectives The aim of this study was to investigate the effect of renin-angiotensin system blockade on outcomes in patients with aortic regurgitation (AR). Background Angiotensin-converting enzyme (ACE) inhibitors have the potential to reduce afterlo